MYXOID ROUND CELL LIPOSARCOMA
Clinical trials for MYXOID ROUND CELL LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MYXOID ROUND CELL LIPOSARCOMA trials appear
Sign up with your email to follow new studies for MYXOID ROUND CELL LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug aims to revive failing cancer fighters in rare sarcomas
Disease control Recruiting nowThis early-phase trial tests an immunotherapy drug called N-803 in up to 8 people with synovial sarcoma or myxoid/round cell liposarcoma whose cancer got worse after a prior cell therapy. N-803 is designed to boost the patient's own immune cells that survived the earlier treatmen…
Matched conditions: MYXOID ROUND CELL LIPOSARCOMA
Phase: EARLY_PHASE1 • Sponsor: Seth Pollack • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Genetically modified NK cells take on rare sarcomas in early trial
Disease control Recruiting nowThis early-phase trial tests a new therapy for people with advanced synovial sarcoma or myxoid/round cell liposarcoma. Participants receive donated natural killer (NK) cells that have been engineered to recognize and attack a protein called NY-ESO-1 found on their cancer cells. T…
Matched conditions: MYXOID ROUND CELL LIPOSARCOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC